1-4 of 4
Robert Robles, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) with Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results from the Pyramid Trial (NCT00931918)

John P. Leonard, MD, Kathryn Kolibaba, MD, James A. Reeves, MD, Anil Tulpule, MD, Ian W. Flinn, MD PhD, Tatjana Kolevska, MD, Robert Robles, MD, Christopher Flowers, MD, Robert Collins, MD, Nicholas J. DiBella, MD, Steven W. Papish, MD, Parameswaran Venugopal, MD, Andrew Horodner, MD, Amir Tabatabai, MD, Julio Hajdenberg, MD, George Mulligan, PhD, Rachel Neuwirth, PhD, Kaveri Suryanarayan, Dixie-Lee Esseltine, MD, Sven de Vos, MD PhD
Journal: Blood
Blood (2015) 126 (23): 811.
https://doi.org/10.1182/blood.V126.23.811.811
Published: 2015
Journal Articles

Immune (Idiopathic) Thrombocytopenic Purpura (ITP): Treatment Pattern and Splenectomy Rate from a Multinational Prospective Observational Study

Francesco Rodeghiero, MD, Axel C. Matzdorff, MD, Tiziano Barbui, MD, Jean- Francois Viallard, MD, PhD, Naveed M. Chowhan, MD, Robert Robles, MD, Boriana Kamenova, MD, Ze Cong, MS, Robert Deuson, PhD, John J. Isitt, MS
Journal: Blood
Blood (2008) 112 (11): 4538.
https://doi.org/10.1182/blood.V112.11.4538.4538
Published: 2008
Journal Articles

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage II, III or IV CLL.

Raul R. Mena, MD, Robert Robles, MD, Michael Auerbach, MD, Mehdi M. Moezi, MD, David Headley, MD
Journal: Blood
Blood (2006) 108 (11): 4978.
https://doi.org/10.1182/blood.V108.11.4978.4978
Published: 2006
Journal Articles

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage III or IV, Low-Grade CLL.

Raul R. Mena, MD, Robert Robles, MD, David W. Nyman, DO, Michael Auerbach, MD, Lalita Pandit, MD
Journal: Blood
Blood (2005) 106 (11): 5045.
https://doi.org/10.1182/blood.V106.11.5045.5045
Published: 2005